Skip to main content
Top
Published in: European Radiology 5/2007

01-05-2007 | Magnetic Resonance

Intra-individual comparison of image contrast in SPIO-enhanced liver MRI at 1.5T and 3.0T

Authors: Marcus von Falkenhausen, Carsten Meyer, Götz Lutterbey, Nuschin Morakkabati, Oliver Walter, Jürgen Gieseke, Renate Blömer, Winfried A. Willinek, Christiane K. Kuhl, Hans H. Schild

Published in: European Radiology | Issue 5/2007

Login to get access

Abstract

The purpose of the study was to examine if the higher susceptibility at 3.0 Tesla (T) compared to 1.5 T will affect the contrast in MR imaging of the liver after application of superparamagnetic iron oxide particles (SPIO). The study was approved by our institutional review board and informed consent was obtained. Seventeen healthy volunteers were examined in a prospective, intra-individual comparative study within one day on a 1.5 T and a 3.0 T MRI system. T2 weighted TSE sequences were acquired after bolus injection of a SPIO contrast agent. Image contrast and signal to noise ratio (SNR) were compared between the field strengths. Image contrast was calculated between the liver tissue and the kidneys / spleen / muscles and fluids. The students’T-test was used for statistical analysis. No influence of the higher field strength could be observed on image contrast except for the liver / muscle contrast. This was due to a distinct SNR increase of the muscle tissue at 3.0 T as a result of their relaxation properties. The higher susceptibility at 3.0 T compared to 1.5 T does not translate into a stronger signal attenuation of the SPIO enhanced liver parenchyma.
Literature
2.
go back to reference Nakada T (2003) Clinical experience on 3.0 T systems in Niigata, 1996 to 2002. Invest Radiol 38:377–384PubMedCrossRef Nakada T (2003) Clinical experience on 3.0 T systems in Niigata, 1996 to 2002. Invest Radiol 38:377–384PubMedCrossRef
3.
go back to reference Kuhl CK, Textor J, Gieseke J et al (2005) Acute and subacute ischemic stroke at high-filed-strength (3.0-T) diffusion weighted MR imaging: intra individual comparative study. Radiology 234:509–516PubMedCrossRef Kuhl CK, Textor J, Gieseke J et al (2005) Acute and subacute ischemic stroke at high-filed-strength (3.0-T) diffusion weighted MR imaging: intra individual comparative study. Radiology 234:509–516PubMedCrossRef
4.
go back to reference Willinek WA, Born M, Simon B et al (2003) Time-of-flight MR angiography: comparison of 3.0-T imaging and 1.5-T imaging-initial experience. Radiology 229:913–920PubMedCrossRef Willinek WA, Born M, Simon B et al (2003) Time-of-flight MR angiography: comparison of 3.0-T imaging and 1.5-T imaging-initial experience. Radiology 229:913–920PubMedCrossRef
5.
go back to reference Frayne R, Goodyear BG, Dickhoff P et al (2003) Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 38:385–402PubMedCrossRef Frayne R, Goodyear BG, Dickhoff P et al (2003) Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 38:385–402PubMedCrossRef
6.
go back to reference Morakkabati-Spitz N, Gieseke J, Kuhl C et al (2006) MRI of the pelvis at 3T: very high spatial resolution with sensitivity encoding and flip angle sweep technique in clinically acceptable scan time. Eur Radiol 16:634–641. DOI 10.1007/s00330-005-0016-1 PubMedCrossRef Morakkabati-Spitz N, Gieseke J, Kuhl C et al (2006) MRI of the pelvis at 3T: very high spatial resolution with sensitivity encoding and flip angle sweep technique in clinically acceptable scan time. Eur Radiol 16:634–641. DOI 10.​1007/​s00330-005-0016-1 PubMedCrossRef
7.
go back to reference Stroszczynski C, Gaffke G, Gretschel S et al (2003) Use of SPIO-enhanced T1-and T2-weighted images for the differentiation of liver lesions: an ROC analysis. Fortschr Röntgenstr 175:1368–1375CrossRef Stroszczynski C, Gaffke G, Gretschel S et al (2003) Use of SPIO-enhanced T1-and T2-weighted images for the differentiation of liver lesions: an ROC analysis. Fortschr Röntgenstr 175:1368–1375CrossRef
8.
go back to reference Reimer P, Jähnke N, Fiebich M et al (2000) Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 217:152–158PubMed Reimer P, Jähnke N, Fiebich M et al (2000) Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 217:152–158PubMed
9.
go back to reference Reimer P, Balzer T (2003) Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 13:1266–1276. DOI 10.1007/s00330-002-1721-7 PubMed Reimer P, Balzer T (2003) Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 13:1266–1276. DOI 10.​1007/​s00330-002-1721-7 PubMed
11.
go back to reference Reimer P, Tombach B (1998) Hepatic MRI with SPIO: detection and characterization of focal liver lesions. Eur Radiol 8:1198–1204PubMedCrossRef Reimer P, Tombach B (1998) Hepatic MRI with SPIO: detection and characterization of focal liver lesions. Eur Radiol 8:1198–1204PubMedCrossRef
12.
go back to reference Shamsi K, Balzer T, Saini S et al (1998) Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging.Radiology 206:365–371PubMed Shamsi K, Balzer T, Saini S et al (1998) Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging.Radiology 206:365–371PubMed
13.
go back to reference Balzer T, Carter EC, Shamsi K et al (1996) Results of a multicenter phase II clinical trial with a new susceptibility contrast medium for magnetic resonance imaging of the liver. Acad Radiol 3:Suppl 2:S417–419PubMedCrossRef Balzer T, Carter EC, Shamsi K et al (1996) Results of a multicenter phase II clinical trial with a new susceptibility contrast medium for magnetic resonance imaging of the liver. Acad Radiol 3:Suppl 2:S417–419PubMedCrossRef
14.
go back to reference Neumann F, Cho CH, Spors B et al (2003) In vitro Vergleich der T2-Relaxivität von Eisenoxidpartikeln im MRT bei 1.5 und 3 Tesla. Fortschr Röntgenstr 175:S237 Neumann F, Cho CH, Spors B et al (2003) In vitro Vergleich der T2-Relaxivität von Eisenoxidpartikeln im MRT bei 1.5 und 3 Tesla. Fortschr Röntgenstr 175:S237
15.
go back to reference De Bazelaire CMJ, Duhamel GD, Rofsky NM, Alsop DC (2004) MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: Preliminary results. Radiology 230:652–659PubMedCrossRef De Bazelaire CMJ, Duhamel GD, Rofsky NM, Alsop DC (2004) MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: Preliminary results. Radiology 230:652–659PubMedCrossRef
16.
go back to reference Reimer P, Rummeny EJ, Daldrup HE et al (1995) Clinical results with Resovist: a phase 2 clinical trial. Radiology 195:489–496PubMed Reimer P, Rummeny EJ, Daldrup HE et al (1995) Clinical results with Resovist: a phase 2 clinical trial. Radiology 195:489–496PubMed
Metadata
Title
Intra-individual comparison of image contrast in SPIO-enhanced liver MRI at 1.5T and 3.0T
Authors
Marcus von Falkenhausen
Carsten Meyer
Götz Lutterbey
Nuschin Morakkabati
Oliver Walter
Jürgen Gieseke
Renate Blömer
Winfried A. Willinek
Christiane K. Kuhl
Hans H. Schild
Publication date
01-05-2007
Publisher
Springer-Verlag
Published in
European Radiology / Issue 5/2007
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-006-0484-y

Other articles of this Issue 5/2007

European Radiology 5/2007 Go to the issue